| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.54 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.06 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.26 | 5e-07 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.24 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |